BioSpace News Archive

Cerus Corporation (Nasdaq: CERS) announced today that Alicia Goodman has been appointed to the role of Chief Human Resources Officer (CHRO).

Affimed N.V. announced that an abstract with a comparison of NK cell redirected by the Company’s innate cell engagers versus CAR-NK cells has been accepted for poster presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer, which will be held on November 1-5, 2023 in San Diego, California.

Cue Biopharma, Inc. announced two poster presentations highlighting the company’s Immuno-STAT™ platform and lead clinical assets CUE-101 and CUE-102, representative of the CUE-100 series, at the Society for Immunotherapy of Cancer’s 38th Anniversary Annual Meeting.

Senti Biosciences, Inc. announced four poster presentations at the Society for Immunotherapy of Cancer 38th Annual Meeting, being held November 1-5, 2023, in San Diego, CA.

Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. that is developing ultra-high concentration nitric oxide as an immunotherapeutic for solid tumors, announced that the Company will present data at the upcoming Society for Immunotherapy of Cancer Annual Meeting 2023, which is scheduled to be held November 3rd – 5th at the San Diego Convention Center in San Diego, California.

Lyell Immunopharma, Inc. announced that six abstracts highlighting its broad pipeline of clinical and preclinical product candidates as well as a shortened TIL manufacturing process have been accepted for presentation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer taking place in San Diego, Nov. 1-5, 2023.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced poster presentations of preclinical data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, taking place in San Diego, CA or virtually from November 1 to 5, 2023.

Genetic Technologies Limited – a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce a partnership with the Gold Coast Private Hospital, a member of Healthscope, to establish a Precision Medicine Clinic at the hospital.

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) today announced, it will present new clinical and pre-clinical data supporting its vision to extend the reach of cancer immunotherapies to new patient populations, in an oral presentation and four poster presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), taking place between 3-5 November 2023, San Diego, CA.

NeoImmuneTech, Inc. (NIT or “NeoImmuneTech”), a clinical-stage T cell-focused biopharmaceutical company, today announced it will present development progress of its main asset, NT-I7 (efineptakin alfa), across two posters at the Society for Immunotherapy of Cancer (SITC) annual meeting, to be held in San Diego, November 1-5, 2023.